The country's developing healthcare ecosystem and expanding medical infrastructure are driving demand for effective diabetes treatments across both urban and rural healthcare applications
While peptide-based GLP-1 receptor agonists such as Exenatide, Liraglutide, Dulaglutide, and Semaglutide have demonstrated strong efficacy, there remains significant interest in developing next-generation therapies
Risks of antibiotic exposures early in life on the developing microbiome
Current guidelines recommend at least 150 minutes of moderate-intensity exercise each week , which could include walking, cycling, swimming, strength training, or whatever gets you inspired to move
Tirzepatid, ein dualer GLP-1/GIP-Agonist, sowie Retatrutid, ein Triple-Agonist, zeigten deutliche Effekte auf Gewichtsreduktion, Leberfett und metabolische Parameter